Fifth Third Bancorp
IPXL

Fifth Third Bancorp’s Impax Laboratories, Inc. IPXL Stock Holding History

Fifth Third Bancorp’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-390
Closed -$9K – 2357
2016
Q3 		$9K Buy
390
+66
+20% +$1.77K ﹤0.01% 1869
2016
Q2 		$9K Sell
324
-1,597
-83% -$52.1K ﹤0.01% 1852
2016
Q1 		$62K Sell
1,921
-621
-24% -$21.8K ﹤0.01% 1251
2015
Q4 		$109K Buy
2,542
+2,355
+1,259% +$94.1K ﹤0.01% 1118
2015
Q3 		$7K Sell
187
-874
-82% -$39.4K ﹤0.01% 2192
2015
Q2 		$49K Sell
1,061
-451
-30% -$21.4K ﹤0.01% 1456
2015
Q1 		$71K Sell
1,512
-416
-22% -$16.6K ﹤0.01% 1310
2014
Q4 		$61K Sell
1,928
-72
-4% -$2.11K ﹤0.01% 1318
2014
Q3 		$47K Sell
2,000
-6
-0.3% -$154 ﹤0.01% 1416
2014
Q2 		$60K Sell
2,006
-9,355
-82% -$252K ﹤0.01% 1355
2014
Q1 		$300K Sell
11,361
-11,268
-50% -$282K ﹤0.01% 831
2013
Q4 		$569K Sell
22,629
-196
-0.9% -$4.37K 0.01% 709
2013
Q3 		$467K Sell
22,825
-772
-3% -$15.9K ﹤0.01% 729
2013
Q2 		$470K Buy
+23,597
New +$419K 0.01% 733

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fifth Third Bancorp's IPXL Position: Q4 2016 in Review

Fifth Third Bancorp sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 390 shares — an estimated $9K sold.

Fifth Third Bancorp first reported a position in IPXL in Q2 2013 and held it in 14 quarters. The position peaked at $569K in Q4 2013. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

  • Fifth Third Bancorp reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
  • Fifth Third Bancorp sold 390 Impax Laboratories, Inc. shares in Q4 2016, an estimated $9K.
  • Fifth Third Bancorp first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 14 quarters.
  • Fifth Third Bancorp's Impax Laboratories, Inc. position peaked at $569K in Q4 2013.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Fifth Third Bancorp's 13F filing for Q4 2016, filed 9 Feb 2017.